GENETICS OF CLOPIDOGREL RESISTANCE: RECENT DATA
Antiplatelet therapy is one of the most importance in therapy of patients with injured coronary, cerebral and peripheral arteries. The standard of acute coronary syndrome patients treatment is double antiplatelet therapy: acetylsalicylic acid with P2Y12receptor blocker. Some distinguished genetic sp...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Russo |
| Julkaistu: |
«FIRMA «SILICEA» LLC
2015-10-01
|
| Sarja: | Российский кардиологический журнал |
| Aiheet: | |
| Linkit: | https://russjcardiol.elpub.ru/jour/article/view/323 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|